Steven Schnittman

3.0k citations

22 papers · 2.2k indexed · 1 hit paper · h-index 17

Co-authors: H. Clifford Lane Anthony S. Fauci Cecil H. Fox Norman P. Salzman Miltiades C. Psallidopoulos F Massari Michael Baseler Thomas M. Folks
Topics: HIV Research and Treatment (17 papers)HIV/AIDS drug development and treatment (13 papers)HIV/AIDS Research and Interventions (10 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: Science Nature Medicine Annals of Internal Medicine
Partner nations: United States South Africa Italy

In The Last Decade

Steven Schnittman

21 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Reservoir for HIV-1 in Human Peripheral Blood Is a T Cell That Maintains Expression of CD4

1989 641 citations Steven Schnittman, H. Clifford Lane et al. Science profile →

Peers

Countries citing papers authored by Steven Schnittman

Since Specialization

Citations

This map shows the geographic impact of Steven Schnittman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Schnittman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Schnittman more than expected).

Fields of papers citing papers by Steven Schnittman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Schnittman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Schnittman. The network helps show where Steven Schnittman may publish in the future.

Co-authorship network of co-authors of Steven Schnittman

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Schnittman. A scholar is included among the top collaborators of Steven Schnittman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Schnittman. Steven Schnittman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents 2011 ·AIDS ·Jennifer J. Kiser,Richard M. Rutstein,Pearl Samson,Bobbie Graham,Grace M. Aldrovandi,Lynne Mofenson,Elizabeth Smith,Steven Schnittman,Terry Fenton,Richard C. Brundage,Courtney V. Fletcher	17
2	Antiviral Activity of Nucleoside Analogues During Short-Course Monotherapy or Dual Therapy 2006 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Glenda Gray,(unknown),James McIntyre,(unknown),Steven Schnittman,(unknown),Jean-Marie Ledeine	12
3	T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment 2003 ·AIDS ·(unknown),Daniel C. Douek,Hernán Valdez,Brenna J. Hill,Dolores M. Peterson,Ian Sanne,Peter J. Piliero,Richard A. Koup,Sylvan B. Green,Steven Schnittman,Michael M. Lederman	37
4	Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive Subjects 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Ian Sanne,Peter J. Piliero,Kathleen Squires,Alexandra Thiry,Steven Schnittman	179
5	Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial 2003 ·AIDS ·David W. Haas,Carlos Zala,Shannon Schrader,Peter J. Piliero,Hans Jaeger,(unknown),Alexandra Thiry,Steven Schnittman,Michael Sension	78
6	Atazanavir plus saquinavir once daily: favorable effects on lipid profiles in patients failing prior protease inhibitor therapy (trial AI424-009) 2002 ·Journal of the American College of Cardiology ·David W. Haas,Carlos Zala,Shannon Schrader,Alexandra Thiry,Rachel T. McGovern,Steven Schnittman	1
7	Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression 2001 ·AIDS ·Diane V. Havlir,Peter B. Gilbert,Kara Bennett,Ann C. Collier,Martin Hirsch,Pablo Tebas,Elizabeth M. Adams,L. Joseph Wheat,Diane Goodwin,Steven Schnittman,(unknown),Douglas D. Richman	62
8	Relationship Between Event Rates and Treatment Effects in Clinical Site Differences Within Multicenter Trials 1999 ·Controlled Clinical Trials ·(unknown),Dennis O. Dixon,Martin McIntosh,Jeffrey M. Albert,Samuel A. Bozzette,Steven Schnittman	6
9	Experience with a cross-study endpoint review committee for AIDS clinical trials 1998 ·AIDS ·(unknown),Frank S. Rhame,Richard W. Price,David C. Perlman,Linnea Capps,James Sampson,Lawrence Deyton,Steven Schnittman,Evelyn J. Fisher,Glenn E. Bartsch,Eric Krum,James D. Neaton	16
10	Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiviral therapy 1998 ·Nature Medicine ·(unknown),Oren J. Cohen,Timothy W. Schacker,Mauro Vaccarezza,Cecilia Graziosi,Gian Paolo Rizzardi,James G. Kahn,Cecil H. Fox,Steven Schnittman,David H. Schwartz,Lawrence Corey,Anthony S. Fauci	101
11	Human Immunodeficiency Virus Proviral DNA from Peripheral Blood and Lymph Nodes Demonstrates Concordant Resistance Mutations to Zidovudine (Codon 215) and Didanosine (Codon 74) 1998 ·The Journal of Infectious Diseases ·Douglas L. Mayers,James Bethel,M A Wainberg,O. S. Weislow,Steven Schnittman	8
12	Preliminary Evidence for Partial Restoration of Immune Function in HIV Type 1 Infection with Potent Antiretroviral Therapies: Clues from the Fourth Conference on Retroviruses and Opportunistic Diseases 1997 ·AIDS Research and Human Retroviruses ·Steven Schnittman,María Laura Fox	17
13	CD8⁺ cytolytic T lymphocytes become infected in vitro in the process of killing HIV‐1‐infected target cells 1994 ·European Journal of Immunology ·Andrea De Maria,Sandra Colombini,Steven Schnittman,Lorenzo Moretta	19
14	A Phase I Study of Interferon-α2b in Combination with Interleukin-2 in Patients with Human Immunodeficiency Virus Infection 1994 ·The Journal of Infectious Diseases ·Steven Schnittman,Susan Vogel,(unknown),H. C. Lane,Richard T. Davey	25
15	Summary of the National Institutes of Health Workshop on Primary Human Immunodeficiency Virus Type 1 Infection ^1,2 1993 ·AIDS Research and Human Retroviruses ·Manette T. Niu,(unknown),Patricia Reichelderfer,Steven Schnittman	22
16	Frequent Detection of HIV-1-Specific mRNAs in Infected Individuals Suggests Ongoing Active Viral Expression in All Stages of Disease 1991 ·AIDS Research and Human Retroviruses ·Steven Schnittman,Jack Greenhouse,H. Clifford Lane,Phillip F. Pierce,Anthony S. Fauci	86
17	Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection 1991 ·Annals of Internal Medicine ·Anthony S. Fauci,Steven Schnittman,Guido Poli,Scott Koenig,Giuseppe Pantaleo	225
18	Increasing Viral Burden in CD4+ T Cells from Patients with Human Immunodeficiency Virus (HIV) Infection Reflects Rapidly Progressive Immunosuppression and Clinical Disease 1990 ·Annals of Internal Medicine ·Steven Schnittman,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	231
19	Host defense againstMycobacterium-avium complex 1988 ·Journal of Clinical Immunology ·Steven Schnittman,H. Clifford Lane,Frank G. Witebsky,(unknown),M D Hoggan,Anthony S. Fauci	42
20	Direct Polyclonal Activation of Human B Lymphocytes by the Acquired Immune Deficiency Syndrome Virus 1986 ·Science ·Steven Schnittman,H. Clifford Lane,(unknown),Thomas M. Folks,Anthony S. Fauci	307

About Steven Schnittman

Steven Schnittman is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 22 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (10 papers). The work is most often cited by research in Virology (1.7k citations), Infectious Diseases (1.3k citations) and Immunology (722 citations). Steven Schnittman has collaborated with scholars based in United States, South Africa and Italy. Frequent co-authors include H. Clifford Lane, Anthony S. Fauci, Cecil H. Fox, Norman P. Salzman, Miltiades C. Psallidopoulos, F Massari, Michael Baseler, Thomas M. Folks, Peter J. Piliero and Anthony S. Fauci. Their work appears in journals such as Science, Nature Medicine and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact